Skip to main content

Amivantamab-vmjw

Placeholder slot
 (A-mih-VAN-tuh-mab)

This page contains brief information about amivantamab-vmjw and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Rybrevant
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Amivantamab-vmjw is approved to treat:

Amivantamab-vmjw is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.

Amivantamab-vmjw is also being studied in the treatment of other types of cancer.

More About Amivantamab-vmjw

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Monoclonal Antibodies

Clinical Trials Accepting Patients

Find Clinical Trials for Amivantamab-vmjw - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: